Cytoplasmic Relocalization of TAR DNA-Binding Protein 43 Is Not Sufficient to Reproduce Cellular Pathologies Associated with ALS In vitro

Heike J. Wobst(Jnana Therapeutics (United States)), Stephen J. Moss(Tufts University)

Frontiers in Molecular Neuroscience

February 23, 2017

10.3389/fnmol.2017.00046

Cited by 31

Related Papers

Antibodies to the GABAB receptor in limbic encephalitis with seizures: case series and characterisation of the antigen

|The Lancet Neurology|2009|912

Postsynaptic GABA<sub>B</sub>Receptor Activity Regulates Excitatory Neuronal Architecture and Spatial Memory

|Journal of Neuroscience|2014|55

The Ability of BDNF to Modify Neurogenesis and Depressive-Like Behaviors Is Dependent upon Phosphorylation of Tyrosine Residues 365/367 in the GABA<sub>A</sub>-Receptor γ2 Subunit

|Journal of Neuroscience|2013|49

Truncation of the TAR DNA-binding protein 43 is not a prerequisite for cytoplasmic relocalization, and is suppressed by caspase inhibition and by introduction of the A90V sequence variant

|PLoS ONE|2017|26